Extension Study to Evaluate Safety and Efficacy of Jaktinib in Patients With Active Ankylosing Spondylitis(AS)

NCT05861128 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

258

Enrollment

INDUSTRY

Sponsor class

Conditions

Ankylosing Spondylitis

Interventions

DRUG: Jaktinib

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd